111 related articles for article (PubMed ID: 25737952)
1. NPY signalling in early osteoblasts controls glucose homeostasis.
Lee NJ; Nguyen AD; Enriquez RF; Luzuriaga J; Bensellam M; Laybutt R; Baldock PA; Herzog H
Mol Metab; 2015 Mar; 4(3):164-74. PubMed ID: 25737952
[TBL] [Abstract][Full Text] [Related]
2. Osteoblastic Actions of the Neuropeptide Y System to Regulate Bone and Energy Homeostasis.
Horsnell H; Baldock PA
Curr Osteoporos Rep; 2016 Feb; 14(1):26-31. PubMed ID: 26872458
[TBL] [Abstract][Full Text] [Related]
3. NPY revealed as a critical modulator of osteoblast function in vitro: new insights into the role of Y1 and Y2 receptors.
Teixeira L; Sousa DM; Nunes AF; Sousa MM; Herzog H; Lamghari M
J Cell Biochem; 2009 Aug; 107(5):908-16. PubMed ID: 19459152
[TBL] [Abstract][Full Text] [Related]
4. Central and peripheral mechanisms of the NPY system in the regulation of bone and adipose tissue.
Shi YC; Baldock PA
Bone; 2012 Feb; 50(2):430-6. PubMed ID: 22008645
[TBL] [Abstract][Full Text] [Related]
5. The osteoblast: an insulin target cell controlling glucose homeostasis.
Clemens TL; Karsenty G
J Bone Miner Res; 2011 Apr; 26(4):677-80. PubMed ID: 21433069
[TBL] [Abstract][Full Text] [Related]
6. Regulation of neuropeptide Y Y1 receptor expression by bone morphogenetic protein 2 in C2C12 myoblasts.
Kurebayashi N; Sato M; Fujisawa T; Fukushima K; Tamura M
Biochem Biophys Res Commun; 2013 Oct; 439(4):506-10. PubMed ID: 24025680
[TBL] [Abstract][Full Text] [Related]
7. Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity.
Lee NJ; Doyle KL; Sainsbury A; Enriquez RF; Hort YJ; Riepler SJ; Baldock PA; Herzog H
J Bone Miner Res; 2010 Aug; 25(8):1736-47. PubMed ID: 20200977
[TBL] [Abstract][Full Text] [Related]
8. Critical interplay between neuropeptide Y and sex steroid pathways in bone and adipose tissue homeostasis.
Allison SJ; Baldock PA; Enriquez RF; Lin E; During M; Gardiner EM; Eisman JA; Sainsbury A; Herzog H
J Bone Miner Res; 2009 Feb; 24(2):294-304. PubMed ID: 18847327
[TBL] [Abstract][Full Text] [Related]
9. NPY modulates PYY function in the regulation of energy balance and glucose homeostasis.
Zhang L; Nguyen AD; Lee IC; Yulyaningsih E; Riepler SJ; Stehrer B; Enriquez RF; Lin S; Shi YC; Baldock PA; Sainsbury A; Herzog H
Diabetes Obes Metab; 2012 Aug; 14(8):727-36. PubMed ID: 22369253
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y Y1 receptor antagonism increases bone mass in mice.
Sousa DM; Baldock PA; Enriquez RF; Zhang L; Sainsbury A; Lamghari M; Herzog H
Bone; 2012 Jul; 51(1):8-16. PubMed ID: 22484690
[TBL] [Abstract][Full Text] [Related]
11. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors.
Henry M; Ghibaudi L; Gao J; Hwa JJ
Obes Res; 2005 Jan; 13(1):36-47. PubMed ID: 15761161
[TBL] [Abstract][Full Text] [Related]
12. Roles for corticotropin-releasing factor receptor type 1 in energy homeostasis in mice.
Sakamoto R; Matsubara E; Nomura M; Wang L; Kawahara Y; Yanase T; Nawata H; Takayanagi R
Metabolism; 2013 Dec; 62(12):1739-48. PubMed ID: 24054833
[TBL] [Abstract][Full Text] [Related]
13. p38α function in osteoblasts influences adipose tissue homeostasis.
Rodríguez-Carballo E; Gámez B; Méndez-Lucas A; Sánchez-Freutrie M; Zorzano A; Bartrons R; Alcántara S; Perales JC; Ventura F
FASEB J; 2015 Apr; 29(4):1414-25. PubMed ID: 25550462
[TBL] [Abstract][Full Text] [Related]
14. Osteoblast specific Y1 receptor deletion enhances bone mass.
Lee NJ; Nguyen AD; Enriquez RF; Doyle KL; Sainsbury A; Baldock PA; Herzog H
Bone; 2011 Mar; 48(3):461-7. PubMed ID: 21040809
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Over-Expression of Neuropeptide Y in Hypothalamic Paraventricular Nucleus Contributes to Adipose Tissue Insulin Resistance Partly via the Y5 Receptor.
Long M; Zhou J; Li D; Zheng L; Xu Z; Zhou S
PLoS One; 2015; 10(5):e0126714. PubMed ID: 25993471
[TBL] [Abstract][Full Text] [Related]
16. Hypothalamic control of bone formation: distinct actions of leptin and y2 receptor pathways.
Baldock PA; Sainsbury A; Allison S; Lin EJ; Couzens M; Boey D; Enriquez R; During M; Herzog H; Gardiner EM
J Bone Miner Res; 2005 Oct; 20(10):1851-7. PubMed ID: 16160743
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic Islet APJ Deletion Reduces Islet Density and Glucose Tolerance in Mice.
Han S; Englander EW; Gomez GA; Rastellini C; Quertermous T; Kundu RK; Greeley GH
Endocrinology; 2015 Jul; 156(7):2451-60. PubMed ID: 25965959
[TBL] [Abstract][Full Text] [Related]
18. Regulation of glucose metabolism and the skeleton.
Ng KW
Clin Endocrinol (Oxf); 2011 Aug; 75(2):147-55. PubMed ID: 21623861
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y expression and function during osteoblast differentiation--insights from transthyretin knockout mice.
Nunes AF; Liz MA; Franquinho F; Teixeira L; Sousa V; Chenu C; Lamghari M; Sousa MM
FEBS J; 2010 Jan; 277(1):263-75. PubMed ID: 19954489
[TBL] [Abstract][Full Text] [Related]
20. Y2 receptor signalling in NPY neurons controls bone formation and fasting induced feeding but not spontaneous feeding.
Qi Y; Fu M; Herzog H
Neuropeptides; 2016 Feb; 55():91-7. PubMed ID: 26444586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
